Preliminary survivorship report on combined intraoperative radiation and hyperthermia treatments for unresectable pancreatic adenocarcinoma.
Five patients with unresectable pancreatic adenocarcinoma were treated with simultaneous intraoperative radiotherapy and intraoperative hyperthermia. Postoperative survivorship averaged 15.8 months, which compares favorably to a previous study in which 19 patients receiving intraoperative radiotherapy without intraoperative hyperthermia survived an average of 6.05 months. Three of the five patients following the experimental protocol of intraoperative radiotherapy and intraoperative hyperthermia with additional external beam radiotherapy are still alive, which may result in average postoperative survivorship exceeding 15.8 months.
Ashayeri
E
E
Department of Radiation Oncology, Howard University Hospital, Washington, DC 20060.
Bonney
G
G
DeWitty
R L
RL
Goldson
A L
AL
Leffall
L D
LD
Thomas
J N
JN
D000230:Adenocarcinoma / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D000368:Aged; D003131:Combined Modality Therapy; D003972:Diathermy; D004219:District of Columbia / Q000453:epidemiology; D006801:Humans; D007430:Intraoperative Care; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D011379:Prognosis; D015996:Survival Rate